TSRL announced the expansion of its laboratories on Avis Drive and the addition of a seasoned pharmaceutical Operations Manager to its team.

Ann Arbor, MI (October 7, 2009) – Therapeutic Systems Laboratory (TSRL, Inc.), a biopharmaceutical company developing oral drug delivery solutions for poorly absorbed drug candidates, announces expansion and staff addition.

Kathleen Jennings is assuming the responsibilities of Director of Laboratory Services at TSRL. In this role, Mrs. Jennings will be leading TSRL’s contract research efforts focusing on preclinical ADME and early stage drug delivery evaluations, with an emphasis on permeability, solubility and dissolution studies required for BCS biowaivers. She brings close to 20 years of GLP bioanalytical experience in support of preclinical and clinical drug development to TSRL. In addition, Mrs. Jennings has a strong background in data management  in compliance with FDA regulations, project management expertise and extensive experience with FDA inspections. In line with the continued growth of TSRL’s contract research, we recently expanded our current facilities at Avis Farms, which now total 7,000 sqft,, 4,800 of which is laboratory space.

Therapeutic Systems Research Laboratories (TSRL), Inc. (www.tsrlinc.com) is a privately held oral drug delivery specialty firm. TSRL is focused on R&D efforts to enhance the oral absorption of investigational and marketed compounds currently not suitable for this most convenient route of drug administration. TSRL provides preclinical development research services in early formulation development, PK/ADME and BCS biowaiver data packages. More detailed information about TSRL is available at the company website www.tsrlinc.com or by contacting Dr. Elke Lipka, Vice President for Business Development, 734 663-4233 x236, elipka@tsrlinc.com.